Oteseconazole
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance.
Journal: Journal of fungi (Basel, Switzerland)
Published: February 20, 2026
Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents.
Journal: Journal of fungi (Basel, Switzerland)
Published: January 14, 2026
New antifungals for the treatment of invasive mold disease.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 05, 2025
Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis.
Journal: Journal of women's health (2002)
Published: November 08, 2025
In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae.
Journal: Microbiology spectrum
Published: June 23, 2025
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.
Journal: Expert review of anti-infective therapy
Published: June 04, 2025
Design, Synthesis, and Biological Activity Evaluation of Deuterated Diphenyl Azole Alcohol-Based CYP51 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Vulvovaginal Candidiasis Caused by Candida krusei (Pichia kudriavzevii ), Still a Formidable Challenge.
Journal: Journal of lower genital tract disease
Published: March 18, 2025
Rising Into Relevance: A Rare Case of Saccharomyces cerevisiae Pyelonephritis in an Immunosuppressed Patient With Exposure to Sourdough Starter.
Journal: Journal of investigative medicine high impact case reports
Published: February 24, 2025
Last Updated: 04/28/2026